ANL 23.10 Decreased By ▼ -0.70 (-2.94%)
ASC 16.10 Decreased By ▼ -0.30 (-1.83%)
ASL 22.25 Decreased By ▼ -0.40 (-1.77%)
BOP 8.55 Increased By ▲ 0.17 (2.03%)
BYCO 8.96 Increased By ▲ 0.15 (1.7%)
FCCL 18.07 Decreased By ▼ -0.40 (-2.17%)
FFBL 24.45 Decreased By ▼ -0.15 (-0.61%)
FFL 17.90 Decreased By ▼ -0.15 (-0.83%)
FNEL 8.40 Decreased By ▼ -0.14 (-1.64%)
GGGL 22.09 Decreased By ▼ -0.21 (-0.94%)
GGL 43.18 Decreased By ▼ -0.77 (-1.75%)
HUMNL 7.02 Decreased By ▼ -0.15 (-2.09%)
JSCL 20.85 Decreased By ▼ -0.73 (-3.38%)
KAPCO 37.90 Decreased By ▼ -0.20 (-0.52%)
KEL 3.61 Increased By ▲ 0.01 (0.28%)
MDTL 3.00 Decreased By ▼ -0.07 (-2.28%)
MLCF 36.30 Decreased By ▼ -0.18 (-0.49%)
NETSOL 153.30 Decreased By ▼ -4.45 (-2.82%)
PACE 5.98 Decreased By ▼ -0.03 (-0.5%)
PAEL 31.20 Decreased By ▼ -0.45 (-1.42%)
PIBTL 9.36 Decreased By ▼ -0.11 (-1.16%)
POWER 7.90 Decreased By ▼ -0.14 (-1.74%)
PRL 20.85 Decreased By ▼ -0.13 (-0.62%)
PTC 10.40 Increased By ▲ 0.02 (0.19%)
SILK 1.67 Decreased By ▼ -0.02 (-1.18%)
SNGP 43.19 Decreased By ▼ -0.56 (-1.28%)
TELE 22.06 Decreased By ▼ -0.64 (-2.82%)
TRG 173.50 Decreased By ▼ -2.41 (-1.37%)
UNITY 36.20 Decreased By ▼ -0.77 (-2.08%)
WTL 3.25 Decreased By ▼ -0.08 (-2.4%)
BR100 4,979 Decreased By ▼ -47.44 (-0.94%)
BR30 24,460 Decreased By ▼ -312.8 (-1.26%)
KSE100 46,636 Decreased By ▼ -284.38 (-0.61%)
KSE30 18,480 Decreased By ▼ -177.85 (-0.95%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,135
6324hr
Pakistan Cases
1,221,261
2,51224hr
4.4% positivity
Sindh
449,349
Punjab
420,615
Balochistan
32,722
Islamabad
103,923
KPK
170,738
Business & Finance

Different age rules for Oxford/AstraZeneca COVID-19 vaccine in EU

  • Some EU countries, though, have limited its use to people under 65 because of a lack of data for older people in clinical trials for the shot.
  • Countries that have recommended the vaccine's use for people between 18 and 64 years old:
08 Feb 2021

The European Medicines Agency last month approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for people over 18 years old.

Some EU countries, though, have limited its use to people under 65 because of a lack of data for older people in clinical trials for the shot.

British regulators have received extra trial data from AstraZeneca supporting their view that the vaccine is effective in the elderly, a vaccines official said on Friday.

The following lists which EU member states' health authorities have so far issued specific age-related recommendations for the British vaccine.

Countries that have recommended the vaccine's use for people between 18 and 64 years old:

AUSTRIA

DENMARK: Health authority said it recommends using the vaccine for people under 65 for now until more data on efficacy among elderly is available.

FRANCE: The Haute Autorite de la Sante (HAS) said people aged 50 to 65 with health issues and medical staff should get priority access.

GERMANY

ICELAND: Iceland, which is a member of the European Free Trade Association, will not be administering the vaccine to people above the age of 65, according to Icelandic media.

NORWAY

PORTUGAL: Portugal's health ministry said the vaccine should preferably be used on under-65s, but that a vaccination for someone older should not be delayed if the AstraZeneca shot is the only one available.

Countries that have given different age-related recommendations:

ITALY: Recommends preferential use of the vaccine for adults aged 55 and under.

POLAND: Will use the vaccine only for people aged 18-60

SPAIN: Approved the vaccine for use in people aged 18 to 55

Sources: Reuters reporting, company press releases, regulatory bodies.

Comments

Comments are closed.